![]() | License: Creative Commons Attribution 4.0 PDF - Published Version (6MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-551404
- DOI to cite this document:
- 10.5283/epub.55140
Abstract
Background: Neurosteroids have recently gained in interest as a treatment strategy for affective disorders. Etifoxine is known for its dual mode of action, one of which is to stimulate endogenous neurosteroid synthesis. The gut microbiome has been studied in affective disorders, but it has not been investigated in the context of human etifoxine or neurosteroid interventions. Methods: We ...

Owner only: item control page